Dabur India Limited · NSE:DABUR
Dabur India — Q4 FY22 Earnings Presentation
29 slides from Dabur India's earnings presentation, May 5, 2022
Slide 1: Investors Communication Presentation cover letter
vJ^Ai ^S^i?. ^r^tf^^" Ref: SEC/SE/2022-23 ^ur India Ltd. May 05, 2022 To, Corporate Relations Department Listing Department BSE Ltd. National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No. C/1, G Block, Bandra - Kurla Mumbai- 400001 Complex,
Slide 2: FY22 & Q4 FY22 Results Presentation
Building Business Purposefully And Sustainably FY22 & Q4 FY22 RESULTS PRESENTATION 5TH MAY 2022
Slide 3: Agenda
AGENDA 1 2 3 4 FY22 Q4 FY22 Q4 FY22 DIVIDEND PERFORMANCE PERFORMANCE BUSINESS UPDATE SUMMARY SUMMARY HIGHLIGHTS Q4 FY22 and FY22 - Results Presentation
Slide 4: Agenda
AGENDA 1 2 3 4 FY22 Q4 FY22 Q4 FY22 DIVIDEND PERFORMANCE PERFORMANCE BUSINESS UPDATE SUMMARY SUMMARY HIGHLIGHTS Q4 FY22 and FY22 - Results Presentation
Slide 5: FY22 Performance Highlights and Summary
Consol Revenue Standalone FY22 | PERFORMANCE HIGHLIGHTS AND SUMMARY Highest annual crosses INR Revenue crosses revenue growth 10,000 cr for INR 8,000 cr for in last 8 years the first time the first time 13.9% 13.8% 15.8% Consolidated Revenue Growth India Standalone International Business Growth Reve
Slide 6: FY22 Consolidated Financials
Revenue from Operations Operating Profit PBT before exceptional PAT Growth % 2-yr CAGR 2-yr CAGR: 11.9% 2-yr CAGR: 12.1% 2-yr CAGR: 13.5% BE* 7.7% 9.6% AE** 2.7% 9.7% FY22 | CONSOLIDATED FINANCIALS 13.9% 12.5% 14.5% 10,889 17.7% 16.8% 20.9% 21.6% 16.0% 20.7% 21.5% 2,254 2,354 2,003 2,056 1,824 1,693
Slide 7: FY22 Domestic FMCG Growth by Verticals
FY21 Sales Contribution FY22 Sales Contribution FY22 | DOMESTIC FMCG GROWTH – BY VERTICALS Food and Beverage Food and Beverage 13.1% 16.9% Healthcare Healthcare 35.9% 39.0% HPC HPC 47.9% 47.2% Healthcare Home & Personal Care (HPC) Food & Beverage (F&B) 2-yr CAGR: 17.8% 2-yr CAGR: 11.1% 2-yr CAGR: 18
Slide 8: FY22 International Business Performance
FY21 Sales Contribution FY22 Sales Contribution FY22 | INTERNATIONAL BUSINESS PERFORMANCE Others Others 2.3% 2.3% International International 26.4% 26.0% Domestic Domestic 71.3% 71.7% International Business grew by 15.8% in CC terms (11.8% in INR) FY22 Constant Currency Growth % 22.2% 21.4% 18.7% 17
Slide 9: Agenda
AGENDA 1 2 3 4 FY22 Q4 FY22 Q4 FY22 DIVIDEND PERFORMANCE PERFORMANCE BUSINESS UPDATE SUMMARY SUMMARY HIGHLIGHTS Q4 FY22 and FY22 - Results Presentation
Slide 10: Q4 FY22 Consolidated Financials
Revenue from Operations Operating Profit PBT before exceptional PAT 2-yr CAGR: 16.2% 2-yr CAGR: 13.5% 2-yr CAGR: 18.1% 2-yr CAGR*: 13.4% LY Growth of 25.3% LY Growth of 25.6% LY Growth of 32.7% LY Growth* of 28% Q4 FY22 | CONSOLIDATED FINANCIALS 7.7% 2.5% 5.1% 0.4%* 18.9% 18.0% 2,518 19.3% 18.9% 16.
Slide 11: Q4 FY22 Domestic FMCG Growth by Verticals
Q4 FY21 Sales Contribution Q4 FY22 Sales Contribution Q4 FY22 | DOMESTIC FMCG GROWTH – BY VERTICALS Food & Food & Beverage Healthcare Beverage Healthcare 15.1% 33.9% 18.6% 33.6% HPC HPC 51.0% 47.8% Healthcare Home & Personal Care (HPC) Food & Beverage (F&B) 2-yr CAGR: 14.9% 2-yr CAGR: 16.9% 2-yr CAG
Slide 12: Q4 FY22 International Business Performance
Q4 FY21 Sales Contribution Q4 FY22 Sales Contribution Q4 FY22 | INTERNATIONAL BUSINESS PERFORMANCE Others Others 2.7% 3.1% International International 28.2% 27.5% Domestic Domestic 69.2% 69.4% International Business grew by 10.7% in CC terms (5.5% in INR) Q4 FY22 Constant Currency Growth % 47.2% 24.
Slide 13: Agenda
AGENDA 1 2 3 4 FY22 Q4 FY22 Q4 FY22 DIVIDEND PERFORMANCE PERFORMANCE BUSINESS UPDATE SUMMARY SUMMARY HIGHLIGHTS Q4 FY22 and FY22 - Results Presentation
Slide 14: Q4 FY22 Business Highlights - Healthcare
Health Supplements Digestives OTC & Ethicals Q4 FY22 | BUSINESS HIGHLIGHTS - HEALTHCARE Growth % 9.7% 1.2% 7.5% 2-year CAGR 13.6% 10.2% 21.3% • Health Supplements recorded • The portfolio saw muted • Driven by strong growth in good growth led by double growth on account of the Honitus and Health Jui
Slide 15: i REP cccceceeccrenees ee ees ae
i REP cccceceeccrenees ee ees ae 4
Slide 16: Galen eifes ast elect
Galen eifes ast elect UAT: SATE, YTS-SATS, Vig-TAACT, et, VASE, STATE, THAME | TAT: YH H et fefear (375-750 mg) Yas se IA a fafecaw S FeMGAR |
Slide 17: Q4 FY22 Business Highlights - HPC
Oral Care Hair Oils Shampoo Home Care Skin & Salon Growth % 1.1% 2.6% 5.6% 11.0% (10.6%) Q4 FY22 | BUSINESS HIGHLIGHTS - HPC 2-year CAGR 19.9% 13.1% 18.7% 17.4% 11.0% • While the toothpaste • While category is • Shampoos portfolio • Robust double-digit • The portfolio was market recorded a 5% seeing
Slide 18: Q4 FY22 Business Highlights - Food & Beverage
Beverages Foods Q4 FY22 | BUSINESS HIGHLIGHTS – FOOD & BEVERAGE Growth % 35.0% 12.5% 2-year CAGR 31.0% 23.7% • Beverage business continued to exhibit strong • Hommade brand continued to perform well driven by innovation momentum across segments and portfolio expansion • In-home and out-of-home portf
Slide 19: Dabur Virgin Coconut Oil
‘a ‘Dabur" VIRGIN COCONUT OIL SUPERFO@@D © 100% NATURAL Creotive Representation
Slide 20: Suggested Usage
SUGGESTED USAGE
Slide 21: ‘Sip my voli
‘Sip my voli
Slide 22: Agenda
AGENDA 1 2 3 4 FY22 Q4 FY22 Q4 FY22 DIVIDEND PERFORMANCE PERFORMANCE BUSINESS UPDATE SUMMARY SUMMARY HIGHLIGHTS Q4 FY22 and FY22 - Results Presentation
Slide 23: Dividend Update
Interim Dividend Final Dividend Total Dividend Dividend per share 2.50 2.70 5.20 (INR) DIVIDEND UPDATE Dividend % 250% 270% 520% Total Dividend (INR cr) 442 477 919 Dividend Payout 50.39% Ratio* *Calculated on PAT before exceptional item
Slide 24: Summarised Financial Statements
SUMMARISED FINANCIAL STATEMENTS Q4 FY22 and FY22
Slide 25: Consolidated P&L
All figures are in INR cr Q4 FY22 Q4 FY21 Y-o-Y (%) FY22 FY21 Y-o-Y (%) Revenue from operations 2,517.8 2,336.8 7.7% 10,888.7 9,561.7 13.9% Other Income 99.1 85.0 16.7% 393.2 325.3 20.9% Total Income 2,616.9 2,421.8 8.1% 11,281.8 9,886.9 14.1% Material Cost 1,323.3 1,197.9 10.5% 5,639.7 4,789.0 17.8
Slide 26: Standalone P&L
All figures are in INR cr Q4 FY22 Q4 FY21 Y-o-Y (%) FY22 FY21 Y-o-Y (%) Revenue from operations 1,852.3 1,721.9 7.6% 8,179.5 7,184.7 13.8% Other Income 92.2 70.5 30.7% 341.6 276.7 23.5% Total Income 1,944.5 1,792.4 8.5% 8,521.1 7,461.4 14.2% Material Cost 1,019.3 924.5 10.3% 4,377.2 3,696.8 18.4% %
Slide 27: Consolidated Balance Sheet
As at As at As at As at Particulars Particulars 31/03/2022 31/03/2021 31/03/2022 31/03/2021 A Assets B Equity and Liabilities 1 Non-current assets 1 Equity (a) Property, plant and equipment 1,968 1,812 (a) Equity share capital 177 177 (b) Capital work-in-progress 167 147 (b) Other Equity 8,205 7,487
Slide 28: Standalone Balance Sheet
As at As at As at As at Particulars Particulars 31/03/2022 31/03/2021 31/03/2022 31/03/2021 A Assets B Equity and Liabilities 1 Non-current assets 1 Equity (a) Property, plant and equipment 1,329 1,131 (a) Equity share capital 177 177 (b) Capital work-in-progress 128 107 (b) Other Equity 5,687 5,214
Slide 29: For more information and updates, visit
For more information and updates, visit: http://www.dabur.com/in/en- us/investor Q4 FY22 and FY22 - Results Presentation